Drug news
CHMP recommends Izba for Ocular Hypertension+Glaucoma-Alcon
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Izba, (travoprost) 30 �g/ml, Eye drops, solution intended for the decrease of elevated intraocular pressure in adult patients with Ocular Hypertension or open angle Glaucoma. The applicant for this medicinal product is Alcon Laboratories (UK) Ltd.